Skip to main content
SpringerLink
Log in

Monoamine oxidase inhibitors as drugs

  • Molecular-Biological Problems in Drug Creation and the Study of their Mechanism of Action
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literature cited

  1. A. Horita, Principles of Psychopharmacology, New York (1970), pp. 279–287.

  2. E. A. Zeller and J. Barsky, Proc. Soc. Exp. Biol. (New York),81, 459–461 (1952).

    Google Scholar 

  3. H. P. Loomer, J. C. Saunders, and N. S. Kline, Psychiatr. Res. Rep. Amer. Psychiat. Assoc., No. 8, 129–141 (1957).

    Google Scholar 

  4. S. Spector, D. Prockop, P. A. Shore, et al., Science,127, 704 (1958).

    Google Scholar 

  5. M. Chessin, E. R. Kramer, and C. T. Scott, J. Pharmacol. Exp. Ther.,119, 453–460 (1957).

    Google Scholar 

  6. M. D. Mashkovskii, Zh. Nevropatol. Psikhiatr., No. 4, 385–395 (1959).

    Google Scholar 

  7. A. I. Yakovleva, N. G. Shakhnazarova, and M. D. Mashkovskii, Farmakol. Toksikol., No. 2, 143–146 (1960).

    Google Scholar 

  8. P. Shore, L. Gillespie, S. Spector, et al., Naturwissenschaften.,45, 340–341 (1958).

    Google Scholar 

  9. M. D. Mashkovskii, Zh. Vses. Khim. Ova, No. 9, 433–437 (1964).

    Google Scholar 

  10. I. P. Lapin, Zh. Vses. Khim. Ova, 438–447.

  11. M. Greenblatt, G. H. Grosser, and H. Wechsler, Am. J. Psychiatry,120, 935–943 (1964).

    Google Scholar 

  12. A. Leitch. and C. P. Seager, Psychopharmacologia (Berlin),4, 72–77 (1963).

    Google Scholar 

  13. J. Janecke, B. C. Schielle, and N. D. Vestre, J. New Drugs,3, 309–316 (1963).

    Google Scholar 

  14. W. Sargant, Br. Med. J.,1, No. 5221, 225–227 (1961).

    Google Scholar 

  15. J. J. Schildkraut, Int. J. Psychiatr.,4, 203–217 (1967).

    Google Scholar 

  16. I. P. Lapin and G. F. Oxenkrug, Lancet,1, 132–136 (1969).

    Google Scholar 

  17. D. F. Klain, Psychopharmacologia (Berlin),5, 397–403 (1964).

    Google Scholar 

  18. P. J. Dally and S. Rohle, Lancet,1, 18–20 (1961).

    Google Scholar 

  19. J. O. Cole, J. Am. Med. Assoc.,190, 448–455 (1964).

    Google Scholar 

  20. G. Ya. Avrutskii, I. Ya. Gurovich, and V. V. Gromova, Pharmacotherapy of Psychic Illnesses [in Russian], Moscow (1974).

  21. C. M. B. Pare, in Monoamine Oxidase and Its Inhibition, Amsterdam (1976), pp. 271–296.

  22. D. Murphy, Adv. Pharmacol. Chemother.,14, 71–105 (1977).

    Google Scholar 

  23. B. Blackwell, Lancet,2, 849–851 (1963).

    Google Scholar 

  24. M. H. Lader, G. Sakales, and M. Tansella, Psychopharmacologia (Berlin),18, 118–123 (1970).

    Google Scholar 

  25. J. M. Van Rossum, Lancet,1, 950–951 (1963).

    Google Scholar 

  26. S. B. Gertner, Nature,183, 750–751 (1959).

    Google Scholar 

  27. C. D. Holdsworth, M. Atkinson, and W. Goldie, Lancet,2, 621–623 (1961).

    Google Scholar 

  28. L. L. Goldberg, J. Am. Med. Assoc.,190, 456–462 (1964).

    Google Scholar 

  29. R. W. Fuller, Progr. Neuro-Psychopharmacol., No. 2, 303–311 (1978).

    Google Scholar 

  30. D. Robinson, A. Nies, and C. Ravaris, Psychopharmacol. Bull.,13, 50–52 (1977).

    Google Scholar 

  31. C. G. Mountjoy, M. Roth, R. F. Garside, et al., Br. J. Psychiatr.,131, 486–492 (1977).

    Google Scholar 

  32. M. S. Lipsedge, et al., Psychopharmacologia (Berlin),32, 67–80 (1973).

    Google Scholar 

  33. A. Coppen, D. M. Shaw, and J. P. Farrell, Lancet,1, 79–81 (1963).

    Google Scholar 

  34. G. D'Elia, L. Hanson, and H. Raotma, Acta Psychiatr. Scand.,57, 239–252 (1978).

    Google Scholar 

  35. R. N. Nando, R. H. Johnson, and H. J. Keogh, Lancet,2, 1164–1167 (1976).

    Google Scholar 

  36. V. Z. Gorkin, L. V. Tat'yanenko, D. M. Krasnokutskaya, et al., Biokhimiya, No. 3, 510–519 (1967).

    Google Scholar 

  37. J. P. Johnston, Biochem. Pharmacol.,17, 1285–1297 (1968).

    Google Scholar 

  38. V. Geover, M. Sandler, F. Owen, et al., Nature,265, 80–81 (1977).

    Google Scholar 

  39. H. Y. T. Jang and N. H. Neff, J. Pharmacol. Exp. Ther.,189, 733–740 (1974).

    Google Scholar 

  40. I. Knoll and K. Magyar, Adv. Biochem. Psychopharmacol.,5, 393–408 (1972).

    Google Scholar 

  41. R. W. Fuller and B. W. Roush, Arch. Int. Pharmacodyn. Ther.,198, 270–276 (1972).

    Google Scholar 

  42. M. D. Houslay, K. F. Tipton, and M. B. H. Yondim, Life Sci.,19, 467–478 (1976).

    Google Scholar 

  43. D. L. Murphy, et al., Biochem. Pharmacol.,27, 1767–1769 (1978).

    Google Scholar 

  44. D. L. Murphy and R. J. Wyatt, Nature,238, 225–226 (1972).

    Google Scholar 

  45. I. I. Kurilova and R. R. Lideman, Zh. Nevropatol. Psikhiatr., No. 9, 1351–1354 (1978).

    Google Scholar 

  46. E. Fischer et al., Experientia,28, 307–308 (1972).

    Google Scholar 

  47. H. C. Subelli et al., Biochem. Pharmacol.,27, 1707–1711 (1978).

    Google Scholar 

  48. D. Wheatly, Br. J. Psychiatr.,117, 573–574 (1970).

    Google Scholar 

  49. L. Tringer, G. Haits, and E. Varga, Hungarian Conference on Therapy and Pharmacological Research. Fifth Proceedings, Budapest (1971), pp. 111–113.

  50. W. Birkmayer, P. Riederer, and L. Amdrozi, Lancet,1, 439–443 (1977).

    Google Scholar 

  51. G. Ya. Aerutskii, V. V. Gromova, and S. G. Zaitsev, Zh. Nevropatol. Psikhiatr., No. 5, 734–741 (1975).

    Google Scholar 

  52. L. G. Ursova, Zh. Nevropatol. Psikhiatr., No. 6, 906–910.

  53. G. M. Rudenko, V. K. Lepakhin, and A. P. Muzychenko, Nov. Lek. Preparaty. Ékspress Informatsiya, No. 5, 2–13 (1977).

    Google Scholar 

  54. E. I. Barshtein and V. A. Tochilov, Nov. Lek. Preparaty. Ekspress Informatsiya, No. 5, 16–23 (1978).

    Google Scholar 

  55. M. D. Mashkovskii, V. Z. Gorkin, et al., Farmakol. Toksikol., No. 5, 531–536 (1975).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. S. Ordzhonikidze All-Union Scientific-Research Institute for Pharmaceutical Chemistry, Moscow

    M. D. Mashkovskii, N. I. Andreeva & A. I. Polezhaeva

Authors
  1. M. D. Mashkovskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. I. Andreeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. I. Polezhaeva
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 14, No. 2, pp. 6–12, February, 1980.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mashkovskii, M.D., Andreeva, N.I. & Polezhaeva, A.I. Monoamine oxidase inhibitors as drugs. Pharm Chem J 14, 81–86 (1980). https://doi.org/10.1007/BF00765902

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00765902

Keywords

Search

Navigation